– UK, London – Kin and Carta plc (LON: KCT), the global digital transformation consultancy, today announced the appointment of Maria Gordian to its Board as Non-Executive Director with effect from 1st November 2021.
“Maria’s extensive business experience which includes executive leadership at Bain, coupled with her academic and clinical background in medicine makes her a unique and rare executive, with a diverse perspective on how to scale and enhance businesses across the globe. Her appointment comes as Kin + Carta continues to seek B Corp Certification for the whole business, following the certification for the Americas division achieved in January and Europe achieved in September. We are delighted to welcome Maria to the Kin + Carta Board and I look forward to working closely with her.” said Board Chairman, John Kerr.
About Maria Gordian
Maria is a highly experienced professional services executive with more than 25 years of management consulting and business leadership experience. She is currently a leader in Bain & Company’s DEI practice and serves as head of its global Diversity, Equity, and Inclusion Council. Recently, she has been leading Bain’s involvement in OneTen, a cross-industry coalition to connect employers with talent partners, leading non-profits and other skill-credentialing organizations that support the development of Black talent. Additionally, she is a partner in Bain’s Healthcare practice, where she advises clients on creating growth strategies, identifying M&A opportunities, and leading geographic expansion efforts across a range of healthcare sectors, including hospitals, pharmaceuticals, biotech, and medical device companies. Before her time at Bain, she worked at another global consulting firm, where she was a partner and leader in its Pharmaceutical and Medical Product practice and helped build the firm’s global Research & Development group.
Her previous experience also includes the Hospital of the University of Pennsylvania, where she was a Radiology Fellow and Robert Wood Johnson Clinical Scholar, as well as Harvard Medical School where she was a Radiology Resident.
Maria Gordian commented: “I am very excited to be joining the Kin + Carta board as a Non-Executive Director. I believe that digital transformation is critical to remaining competitive in today’s world. That is why I’m eager to support Kin + Carta on its continued growth aspirations, helping companies across sectors embark on their digital transformation journeys. Although I was first attracted to Kin + Carta for its strategic vision and foresight, I have remained wholly impressed by its excellent team and ability to execute on innovative plans.”
Maria completed her BA at Harvard University, before achieving her MD at Tufts University School of Medicine, and an MBA from The Wharton School of the University of Pennsylvania.
About Kin + Carta
Kin + Carta is a London Stock Exchange-listed global digital transformation consultancy committed to working alongside clients to build a world that works better for everyone.
Kin + Carta’s 1,700 strategists, engineers, and creatives around the world bring the connective power of technology, data, and experience to the world’s most influential companies – helping them to accelerate their digital roadmap, rapidly innovate, modernize their systems, enable their teams, and optimize for continued growth. Headquartered in London and Chicago with offices across three continents, the border-less model of service allows for the best minds to be connected to collaborate on client challenges.
With purpose at its core, Kin + Carta is a Certified B Corporation in the United States and Europe, meeting the highest standards of verified social and environmental performance, public transparency, and accountability to balance the triple bottom line of people, planet, and profit.
For more information: https://kinandcarta.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.